This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

ImmunoCellular Therapeutics Ltd (IMUC)

AMEX: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 23.22M 27.65M 26.22M 6.65M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 1.22M 763.30K 714.51K 91.29K
Total Current Assets 24.44M 28.41M 26.93M 6.74M
Property, Plant & Equipment, Gross 202.26K 185.38K 151.57K 105.86K
Accumulated Depreciation & Depletion 154.90K 118.93K 75.28K 29.46K
Property, Plant & Equipment, Net 47.36K 66.44K 76.29K 76.40K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 689.03K 464.58K 11.74K 329.90K
Total Non-Current Assets 736.39K 531.03K 88.02K 406.30K
Liabilities & Shareholder Equity
Total Assets 25.18M 28.94M 27.02M 7.15M
Accounts Payable 322.00K 861.03K 732.85K 1.32M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 1.29M 1.40M 1.10M 1.76M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 597.72K 1.06M 2.85M 2.16M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 597.72K 1.06M 2.85M 2.16M
Total Liabilities 1.89M 2.47M 3.95M 3.92M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 23.29M 26.47M 23.07M 3.23M
Common Par 6.36K 5.75K 5.15K 2.86K
Additional Paid In Capital 84.63M 78.44M 66.23M 31.90M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -61.35M -51.97M -43.17M -28.67M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 23.29M 26.47M 23.07M 3.23M
Total Equity 23.29M 26.47M 23.07M 3.23M
Total Liabilities & Stock Equity 25.18M 28.94M 27.02M 7.15M
Total Common Shares Outstanding 63.60M 57.54M 51.50M 28.61M
Preferred Shares 0.00 0.00 0.00 152.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 59.92M 54.28M 41.80M 27.45M
Diluted Weighted Shares Outstanding 59.92M 54.28M 41.80M 27.45M
Number of Employees 4 3 5 4
Number of Part-Time Employees 4 3 2 0
IMUC News

IMUC ImmunoCellular Therapeutics Ltd

Analysts Ratings for IMUC

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET IMUC ANALYST REPORT

Brokerage Partners

IMUC Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs